KP Tissue Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Other Receivables	1.8	1.8	2.45	2.37	1.99	Upgrade
Receivables	1.8	1.8	2.45	2.37	1.99	Upgrade
Total Current Assets	1.8	1.8	2.45	2.37	1.99	Upgrade
Long-Term Investments	69.8	69.52	68.16	79.34	78.73	Upgrade
Total Assets	71.6	71.32	70.61	81.71	80.72	Upgrade
Other Current Liabilities	1.8	1.8	2.25	1.96	4.04	Upgrade
Total Current Liabilities	1.8	1.8	2.25	1.96	4.04	Upgrade
Long-Term Deferred Tax Liabilities	-	-	-	5.72	0.81	Upgrade
Total Liabilities	1.8	1.8	2.25	7.68	4.85	Upgrade
Common Stock	23	22.76	22.56	22.38	21.84	Upgrade
Additional Paid-In Capital	144.82	144.82	144.82	144.82	144.82	Upgrade
Retained Earnings	-114.99	-116.67	-115.03	-108.01	-103.56	Upgrade
Comprehensive Income & Other	16.96	18.61	16.01	14.84	12.77	Upgrade
Shareholders' Equity	69.8	69.52	68.36	74.03	75.87	Upgrade
Total Liabilities & Equity	71.6	71.32	70.61	81.71	80.72	Upgrade
Filing Date Shares Outstanding	10.02	9.99	9.97	9.95	9.93	Upgrade
Total Common Shares Outstanding	10.02	9.99	9.96	9.95	9.9	Upgrade
Working Capital	-	-	0.2	0.41	-2.05	Upgrade
Book Value Per Share	6.97	6.96	6.86	7.44	7.67	Upgrade
Tangible Book Value	69.8	69.52	68.36	74.03	75.87	Upgrade
Tangible Book Value Per Share	6.97	6.96	6.86	7.44	7.67	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.